Search
for
Sort by
Research 31–60 of 1000+
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- The PDGF/PDGFR pathway as a drug target
- Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- A Case of Cicatricial Alopecia Associated with Erlotinib
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- Nilontinib induced keratosis pilaris atrophicans
- Dasatinib-Induced Leukotrichia in a Patient With Chronic Myelogenous Leukemia
- Rapid hair depigmentation in patient treated with pazopanib
- Erlotinib-Associated Alopecia in a Lung Cancer Patient
- Hair graying and loss induced by imatinib mesylate
- Gefitinib-induced hair alterations: Figure 1
- An overview of management of drug-induced hair and nail disorders
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Periocular Manifestations of Afatinib Therapy
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case
- Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature
- The Dark Side of Gefitinib: Reflectance Confocal Microscopy Applied to Hair Hyperpigmentation
- Unusual progression of renal cell carcinoma with carcinomatosis peritoneii and Krukenberg tumour and alopecia with sunitinib therapy in young female
- Hair Growth After Gefitinib Treatment
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Drug-induced scarring and permanent alopecia
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress
- Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung
- Severe scarring alopecia associated with combinational use of ficlatuzumab and gefitinib: a clinical and immunohistochemistry study
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Axitinib-induced repigmentation of grey hair in a patient with metastatic renal cell carcinoma
- Hair Re-Pigmentation After Nilotinib
- Ponatinib-induced pityriasis rubra pilaris-like adnexal dysmaturation: A case report